Trypanosoma cruzi infection in transfusion medicine

被引:15
作者
Gomez, Lina Andrea [1 ]
Gutierrez, Fredy R. S. [2 ]
Penuela, Oscar Andres [3 ]
机构
[1] Univ Sabana, Sch Med, Biomed Res Ctr CIBUS, Chia, Colombia
[2] Antonio Naririo Univ, Sch Med, Lab Immunol, Bogota, Colombia
[3] Bayer SA, Med Affairs, Bogota, Colombia
关键词
Hemoparasite; Trypanosoma cruzi; Blood banks; Blood safety; Hemovigilance; Epidemiological factors; CHAGAS-DISEASE; BLOOD-DONORS; PHOTOCHEMICAL TREATMENT; PATHOGEN INACTIVATION; AMOTOSALEN HCL; TRANSMISSION; EFFICACY; ASSAY; PREVENTION; STRATEGIES;
D O I
10.1016/j.htct.2018.12.001
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction: Infection by Trypanosome cruzi is challenging to blood bank supplies in terms of accurate diagnosis, mostly due to its clinical complexity. Infected individuals may remain asymptomatic for years, albeit they may have circulating parasites potentially transferable to eventual receptors of a transfusion. Objective: Although risk donors are systematically excluded through a survey, an important residual risk for transmission remains, evidencing the need to implement additional actions for the detection of T. cruzi in blood banks. Method: A review of the scientific literature is presented with the objective of identifying relevant publications on this subject. Results: We discuss the diagnostic considerations of this chronic infection on transfusion medicine and some recent advances in the processing of blood and derivatives units. Conclusion: Finally, recommendations are made on how the transmission of T. cruzi can be avoided through the implementation of better diagnostic and pathogen control measures at blood banks. (C) 2019 Associacao Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published by Elsevier Editora Ltda. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
引用
收藏
页码:262 / 267
页数:6
相关论文
共 57 条
[1]  
[Anonymous], 2002, Control of Chagas disease: second report of the WHO expert committee
[2]  
Battaglia A., 1949, DIA MED, V28, P1086
[3]  
Behrend Markus, 2002, Biomedica, V22, P39
[4]   Acute and Congenital Chagas Disease [J].
Bern, Caryn ;
Martin, Diana L. ;
Gilman, Robert H. .
ADVANCES IN PARASITOLOGY, VOL 75: CHAGAS DISEASE, PT A, 2011, 75 :19-47
[5]  
Camargo M E, 1986, Bull Pan Am Health Organ, V20, P233
[6]   Pathogen inactivation of Trypanosoma cruzi in plasma and platelet concentrates using riboflavin and ultraviolet light [J].
Cardo, Lisa J. ;
Salata, Jeanne ;
Mendez, Juan ;
Reddy, Heather ;
Goodrich, Raymond .
TRANSFUSION AND APHERESIS SCIENCE, 2007, 37 (02) :131-137
[7]  
Carlier Y, 2005, REV SOC BRAS MED TRO, V38, P114
[8]   The Costs of Preventing and Treating Chagas Disease in Colombia [J].
Castillo-Riquelme, Marianela ;
Guhl, Felipe ;
Turriago, Brenda ;
Pinto, Nestor ;
Rosas, Fernando ;
Martinez, Monica Florez ;
Fox-Rushby, Julia ;
Davies, Clive ;
Campbell-Lendrum, Diarmid .
PLOS NEGLECTED TROPICAL DISEASES, 2008, 2 (11)
[9]   The efficacy of photochemical treatment with amotosalen HCl and ultraviolet A (INTERCEPT) for inactivation of Trypanosoma cruzi in pooled buffy-coat platelets [J].
Castro, Emma ;
Girones, Nuria ;
Bueno, Jose Luis ;
Carrion, Javier ;
Lin, Lily ;
Fresno, Manuel .
TRANSFUSION, 2007, 47 (03) :434-441
[10]   Evaluation of a prototype Trypanosoma cruzi antibody assay with recombinant antigens on a fully automated chemiluminescence analyzer for blood donor screening [J].
Chang, Chi-Deu ;
Cheng, Kevin Y. ;
Jiang, Lily X. ;
Salbilla, Vince A. ;
Haller, Alla S. ;
Yem, Alex W. ;
Bryant, Jane D. ;
Kirchhoff, Louis V. ;
Leiby, David A. ;
Schochetman, Gerald ;
Shah, Dinesh O. .
TRANSFUSION, 2006, 46 (10) :1737-1744